- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (329)
7 result(s) found for: Brachial vein.
Displaying page 1 of 1.
EudraCT Number: 2005-004901-27 | Sponsor Protocol Number: HA007 | Start Date*: 2006-05-24 |
Sponsor Name:Nuvelo | ||
Full Title: A Phase 3, Multicenter, Multi-national, Randomized, Double-Blind, Placebo-Controlled study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects with Acute Peripheral Arterial Occlusion (N... | ||
Medical condition: Acute Peripheral Arterial Occlusion (acute PAO) is to peripheral vascular disease what acute coronary syndromes are to atherosclerotic heart disease and what stroke is to atherosclerotic cerebrovas... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) FI (Prematurely Ended) DK (Completed) HU (Completed) NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002122-22 | Sponsor Protocol Number: 02-VLU-003 | Start Date*: 2005-06-24 |
Sponsor Name:Intercytex Limited | ||
Full Title: A prospective, multi-centre, double blind, randomized, placebo controlled trial to evaluate the safety and efficacy of ICXP007 in a phase III trial with four-layer therapeutic compression, for trea... | ||
Medical condition: Venous Insufficiency Leg Ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010062-33 | Sponsor Protocol Number: ABH-DERMAGRAFT-001-08 | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:Advanced BioHealing Inc | |||||||||||||
Full Title: A Prospective, Multi-center, Randomized, Controlled Clinical Investigation of Dermagraft® in Subjects with Venous Leg Ulcers | |||||||||||||
Medical condition: Venous leg ulcers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Completed) GB (Completed) EE (Completed) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002950-67 | Sponsor Protocol Number: HA004 | Start Date*: 2005-04-25 | |||||||||||
Sponsor Name:Nuvelo, Inc. | |||||||||||||
Full Title: Phase 3, Multi-center, Multi-National, Randomized, partical double-blind, Placebo controlled study to evaluate the efficacy and safety of Alfimeprase in subjects with acute peripheral arterial occl... | |||||||||||||
Medical condition: Acute peripheral arterial occlusion (PAO) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) DE (Completed) AT (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004877-38 | Sponsor Protocol Number: PREVENT-MINS | Start Date*: 2021-06-18 | |||||||||||
Sponsor Name:Uniwersytet Jagielloński - Collegium Medicum | |||||||||||||
Full Title: Ivabradine for PREVENTion of Myocardial Injury after Noncardiac Surgery (MINS) - PREVENT-MINS Trial | |||||||||||||
Medical condition: Myocardial Injury after Noncardiac Surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002695-34 | Sponsor Protocol Number: CS-201 | Start Date*: 2009-01-23 | |||||||||||
Sponsor Name:Kringle Pharma Europe AB | |||||||||||||
Full Title: A Phase I/II Double-Blind, Dose Ranging, Vehicle Controlled, Randomized, Parallel Groups, Safety, Tolerability and Efficacy Study of ChronSeal® (5-amino-acid deleted recombinant human Hepatocyte Gr... | |||||||||||||
Medical condition: Non-malignant full skin chronic venous leg ulcers of an area 3 - 20 cm2. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001069-28 | Sponsor Protocol Number: D5881C00004 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia (STRENGTH) | |||||||||||||
Medical condition: Severe persistent Hypertriglyceridemia in High Cardiovascular Risk Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) GB (Prematurely Ended) EE (Completed) LT (Prematurely Ended) HU (Prematurely Ended) IT (Prematurely Ended) DK (Prematurely Ended) NL (Prematurely Ended) PL (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
